Advertisement
Fidelity Select Biotechnology Portfolio

FBIOX News Today: Stay Updated with the Latest Fidelity Select Biotechnology Portfolio News in Real Time

Find FBIOX news now at Meyka AI. Stay informed with the latest Fidelity Select Biotechnology Portfolio stocks updates, including price news, market analysis, and expert insights.

FBIOXNASDAQ
HealthcareBiotechnology
$24.94
$0.39(1.59%)
U.S. Market is Open · 12:27
Advertisement
ASX Blue-Chip Stocks Plunge $60B in Value Over 12 Months, June 11
📅 in about 4 hours

ASX Blue-Chip Stocks Plunge $60B in Value Over 12 Months, June 11

CSL, Cochlear, WiseTech and Xero have fallen 60% in 12 months, losing $60 billion in combined market value on the ASX.

Read more 12
Starbucks Weighs Japan Stake Sale Worth Up to $3.1 Billion Amid Global Restructuring
📅 in about 3 hours

Starbucks Weighs Japan Stake Sale Worth Up to $3.1 Billion Amid Global Restructuring

Starbucks is reportedly exploring the sale of its stake in its Japanese business in a deal that could be valued at as much as $3.1 billion. The move comes as the coffee giant continues a broader global restructuring effort aimed at improving efficiency, strengthening profitability, and focusing on long-term growth opportunities. The potential transaction has…

Read more 12
FTSE 100 Dips 44.98 Points (-0.44%) to 10,182.35 as Oil Falls and Treasury Yields Rise
📅 in about 3 hours

FTSE 100 Dips 44.98 Points (-0.44%) to 10,182.35 as Oil Falls and Treasury Yields Rise

The FTSE 100 ended the trading session lower, falling 44.98 points, or 0.44%, to close at 10,182.35. The decline came as falling oil prices and rising U.S. Treasury yields created headwinds for investors across global financial markets. The UK’s benchmark index faced pressure from energy stocks and other interest rate-sensitive sectors. Investors remained cautious as…

Read more 12
WH Smith Cuts Profit Outlook to £75–£90M and Plans £100M Equity Raise Amid Travel Slowdown
📅 3 minutes ago

WH Smith Cuts Profit Outlook to £75–£90M and Plans £100M Equity Raise Amid Travel Slowdown

WH Smith has lowered its full-year profit outlook to a range of £75 million to £90 million, reflecting weaker-than-expected performance in its travel retail segment. The announcement also included plans for a £100 million equity raise, signaling increased financial caution as global travel demand slows. The update triggered concern among investors in the stock market,…

Read more 12
SpaceX IPO Could Trigger Crypto Selloff as Investors Chase $75 Billion Listing
📅 10 minutes ago

SpaceX IPO Could Trigger Crypto Selloff as Investors Chase $75 Billion Listing

The potential SpaceX IPO has become one of the most closely watched events in global financial markets. Reports suggest that a future public listing could value the company at around $75 billion, making it one of the largest IPOs in history. Investors are now speculating that such a massive listing could trigger a shift in…

Read more 12
SoftBank Stock (TYO:9984) Falls 10% as $6 Billion Loan Talks Linked to OpenAI Stake Stall
📅 2 hours ago

SoftBank Stock (TYO:9984) Falls 10% as $6 Billion Loan Talks Linked to OpenAI Stake Stall

SoftBank Stock came under significant pressure after reports emerged that discussions regarding a $6 billion loan package tied to a potential OpenAI-related investment had stalled. Investors reacted quickly to the news, sending shares of SoftBank Group down approximately 10% in one of the company’s largest single-session declines in recent months. The drop highlights growing concerns…

Read more 12
Steadfast Shares Soar 36% After A$7.7 Billion Takeover Bid From Amwins, Dragoneer
📅 2 hours ago

Steadfast Shares Soar 36% After A$7.7 Billion Takeover Bid From Amwins, Dragoneer

Shares of Steadfast surged 36% after the insurance broking giant received a takeover proposal valued at approximately A$7.7 billion from a consortium led by Amwins and Dragoneer. The announcement immediately attracted investor attention and became one of the biggest stories in the Australian stock market. The proposed deal represents a significant premium over Steadfast’s previous…

Read more 12
Concord Biotech Shares Jump 5.9% After US FDA Approves Tofacitinib Arthritis Drug
📅 2 hours ago

Concord Biotech Shares Jump 5.9% After US FDA Approves Tofacitinib Arthritis Drug

Shares of Concord Biotech saw strong buying interest after a key global development. The stock rose around 5.9% in recent trading sessions after news of a US FDA approval related to its Tofacitinib-based arthritis drug. The trigger is important. The US Food and Drug Administration (FDA) approval opens doors to the world’s largest pharmaceutical market….

Read more 12
All Ordinaries (XAO) Up 0.36% Today (+32.20) as ASX Gold Stock Surges 58% in a Year Despite 1% 12-Month Index Drop
📅 3 hours ago

All Ordinaries (XAO) Up 0.36% Today (+32.20) as ASX Gold Stock Surges 58% in a Year Despite 1% 12-Month Index Drop

The All Ordinaries index closed higher today, adding 32.20 points or 0.36%, as strength in mining and gold-related shares helped lift the broader Australian market. The positive session came despite the benchmark index remaining approximately 1% lower over the past 12 months, highlighting the uneven performance across different sectors of the Australian stock market. One…

Read more 12

FBIOX News FAQ